GIP mediates the uptake, storage and synthesis of fatty acids and triglycerides in adipocytes, especially under conditions of hyperinsulinemia (97–99) and it seems likely that GIPR-blocking agents and/or Gipr knock-out achieve some of their protection from diet-induced weight gain at the level of the adipose tissue. The gene discussed is GIPR; the disease is Hyperinsulinemia.